ELIZABETH HILL to Drug Resistance, Neoplasm
This is a "connection" page, showing publications ELIZABETH HILL has written about Drug Resistance, Neoplasm.
Connection Strength
0.028
-
Remission and Progression-Free Survival in Patients With Newly Diagnosed Multiple Myeloma Treated With Carfilzomib, Lenalidomide, and Dexamethasone: Five-Year Follow-up of a Phase 2 Clinical Trial. JAMA Oncol. 2018 12 01; 4(12):1781-1783.
Score: 0.028